Researcher Profiles

Return to member profile

Isaac Yi Kim, MD, PhD

Publications since 2011

Lee, G. T. Ha, Y. S. Jung, Y. S. Moon, S. K. Kang, H. W. Lee, O. J. Joung, J. Y. Choi, Y. H. Yun, S. J. Kim, W. J. Kim, I. Y. DHCR24 is an Independent Predictor of Progression in Patients with Non-Muscle-Invasive Urothelial Carcinoma, and Its Functional Role is Involved in the Aggressive Properties of Urothelial Carcinoma Cells. Ann Surg Oncol, 21 Suppl 4:538-545, . (PMID: 24562935)

Faiena, I. Singer, E. A. Pumill, C. Kim, I. Y. Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review). Int J Oncol, 45:2193-2198, . (PMID: 25340386, PMCID: PMC4215584)

Yun, S. J. Yan, C. Jeong, P. Kang, H. W. Kim, Y. H. Kim, E. A. Lee, O. J. Kim, W. T. Moon, S. K. Kim, I. Y. Choi, Y. H. Kim, W. J. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH. Ann Surg Oncol, In process, . (PMID: 25348783)

Ha, Y. S. Yu, J. Salmasi, A. H. Patel, N. Parihar, J. Singer, E. A. Kim, J. H. Kwon, T. G. Kim, W. J. Kim, I. Y. Prostate-specific Antigen Density Toward a Better Cutoff to Identify Better Candidates for Active Surveillance. Urology, 84:365-371, . (PMID: 24925834)

Ha, Y. S. Kim, I. Y. Enzalutamide: looking back at its preclinical discovery. Expert Opin Drug Discov, 9:837-845, . (PMID: 24820058)

Ha, Y. S. Kang, D. I. Kim, J. H. Joung, J. Y. Yu, J. Parihar, J. S. Salmasi, A. H. Horie, S. Kim, W. J. Yi Kim, I. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy. Can J Urol, 21:7290-7297, . (PMID: 24978359)

Kang, H. W. Tchey, D. U. Yan, C. Kim, W. T. Kim, Y. J. Yun, S. J. Lee, S. C. Choi, Y. H. Kim, I. Y. Kim, W. J. The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer. Urol Oncol, 32:458-465, . (PMID: 24411789)

Jin, X. Yun, S. J. Jeong, P. Kim, I. Y. Kim, W. J. Park, S. Diagnosis of bladder cancer and prediction of survival by urinary metabolomics. Oncotarget, 5:1635-1645, . (PMID: 24721970, PMCID: PMC4039236)

Lee, G. T. Kang, D. I. Ha, Y. S. Jung, Y. S. Chung, J. Min, K. Kim, T. H. Moon, K. H. Chung, J. M. Lee, D. H. Kim, W. J. Kim, I. Y. Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction. Br J Cancer, 110:1634-1644, . (PMID: 24518599, PMCID: PMC3960605)

Kim, Y. H. Kim, W. T. Jeong, P. Ha, Y. S. Kang, H. W. Yun, S. J. Moon, S. K. Choi, Y. H. Kim, I. Y. Kim, W. J. Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2. J Korean Med Sci, 29:351-356, . (PMID: 24616583, PMCID: PMC3945129)

Hong, J. H. Kim, I. Y. Nonmetastatic Castration-Resistant Prostate Cancer. Korean J Urol, 55:153-160, . (PMID: 24648868, PMCID: PMC3956942)

Parihar, J. S. Ha, Y. S. Kim, I. Y. Bladder neck contracture-incidence and management following contemporary robot assisted radical prostatectomy technique. Prostate Int, 2:12-18, . (PMID: 24693529, PMCID: PMC3970984)

Woo, S. H. Kang, D. I. Ha, Y. S. Salmasi, A. H. Kim, J. H. Lee, D. H. Kim, W. J. Kim, I. Y. Comprehensive Analysis of Sexual Function Outcome in Prostate Cancer Patients after Robot-Assisted Radical Prostatectomy. J Endourol, 28:172-177, . (PMID: 23987521)

Bansal, N. Davis, S. Tereshchenko, I. Budak-Alpdogan, T. Zhong, H. Stein, M. N. Kim, I. Y. Dipaola, R. S. Bertino, J. R. Sabaawy, H. E. Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion. Prostate, 74:187-200, . (PMID: 24154958, PMCID: PMC3939797)

Kwon, S. J. Lee, G. T. Lee, J. H. Iwakura, Y. Kim, W. J. Kim, I. Y. Mechanism of pro-tumorigenic effect of BMP-6: neovascularization involving tumor-associated macrophages and IL-1a. Prostate, 74:121-133, . (PMID: 24185914)

Kang, J. H. Ha, Y. S. Kim, S. Yu, J. Patel, N. Parihar, J. S. Salmasi, A. H. Kim, W. J. Kim, I. Y. Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomy. BMC Urol, 14:30, . (PMID: 24708639, PMCID: PMC4005471)

Ha, Y. S. Lee, G. T. Kim, Y. H. Kwon, S. Y. Choi, S. H. Kim, T. H. Kwon, T. G. Yun, S. J. Kim, I. Y. Kim, W. J. Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma. World J Surg Oncol, 12:288, . (PMID: 25227434, PMCID: PMC4176564)

Kang, H. W. Yang, J. B. Kwon, W. A. Lee, Y. S. Kim, W. T. Kim, Y. J. Yun, S. J. Lee, S. C. Kim, I. Y. Kim, W. J. Diagnostic role of prostate resection in the elderly patients who experience significant co-morbidity with a high clinical suspicion of prostate cancer. J Korean Med Sci, 28:1796-1800, . (PMID: 24339711, PMCID: PMC3857377)

Joung, J. Y. Ha, Y. S. Singer, E. A. Ercolani, M. C. Favaretto, R. L. Lee, D. H. Kim, W. J. Lee, K. H. Kim, I. Y. Use of a Hyaluronic Acid-Carboxymethylcellulose Adhesion Barrier on the Neurovascular Bundle and Prostatic Bed to Facilitate Earlier Recovery of Erectile Function After Robot-Assisted Prostatectomy: An Initial Experience. J Endourol, 27:1230-1235, . (PMID: 23879531)

Kim, I. Y. Editorial comment. Urology, 82:583, . (PMID: 23876585)

Shim, U. J. Lee, I. S. Kang, H. W. Kim, J. Kim, W. T. Kim, I. Y. Ryu, K. H. Choi, Y. H. Moon, S. K. Kim, Y. J. Yun, S. J. Lee, S. C. Kim, W. J. Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer. Korean J Urol, 54:631-637, . (PMID: 24044099, PMCID: PMC3773595)

Kim, Y. J. Yoon, H. Y. Kim, J. S. Kang, H. W. Min, B. D. Kim, S. K. Ha, Y. S. Kim, I. Y. Ryu, K. H. Lee, S. C. Kim, W. J. HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling. Int J Cancer, 133:1135-1142, . (PMID: 23436614)

Kim, I. Y. Ohtsuki, C. Coughlan, A. Placek, L. Wren, A. W. Towler, M. R. Characteristics of glass ionomer cements composed of glass powders in CaO-SrO-ZnO-SiO system prepared by two different synthetic routes. J Mater Sci Mater Med, In process, . (PMID: 23918526)

Kim, J. H. Ha, Y. S. Jeong, S. J. Kim, S. Kim, W. J. Jang, T. L. Kim, I. Y. Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite survey. Prostate Cancer Prostatic Dis, In process, . (PMID: 23917307)

Kim, I. Y. Modi, P. K. Sadimin, E. Ha, Y. S. Kim, J. H. Skarecky, D. Cha, D. Y. Wambi, C. O. Ou, Y. C. Yuh, B. Park, S. Llukani, E. Albala, D. M. Wilson, T. Ahlering, T. Badani, K. Ahn, H. Lee, D. I. May, M. Kim, W. J. Lee, D. H. Detailed Analysis of Prostate Cancer Patients with Metastasis to the Prostatic Anterior Fat Pad Lymph Nodes: a Multi-Institution Study. J Urol, 190:527-534, . (PMID: 23485503)

Joung, J. Y. Ha, Y. S. Kim, I. Y. Radium Ra 223 dichloride in castration-resistant prostate cancer. Drugs Today (Barc), 49:483-490, . (PMID: 23977665)

Lee, G. T. Jung, Y. S. Ha, Y. S. Kim, J. H. Kim, W. J. Kim, I. Y. Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages. Cancer Sci, 104:1027-1032, . (PMID: 23710822)

Lee, J. H. Lee, G. T. Woo, S. H. Ha, Y. S. Kwon, S. J. Kim, W. J. Kim, I. Y. Bone Morphogenetic Protein-6 in Renal Cell Carcinoma Promotes Tumor Proliferation via M2 Polarization of Tumor-Infiltrating Macrophages through Interleukin-10. Cancer Res, 73:3604-3614, . (PMID: 23633487)

Shao, Y. H. Kim, S. Moore, D. F. Shih, W. Lin, Y. Stein, M. Kim, I. Y. Lu-Yao, G. L. Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis. Eur Urol, In process, . (PMID: 23759328)

Kim, J. H. Ha, Y. S. Jeong, S. J. Lee, D. H. Kim, W. J. Kim, I. Y. Impact of Robot-assisted Radical Prostatectomy on Lower Urinary Tract Symptoms and Predictive Factors for Symptom Changes: A Longitudinal Study. Urology, 81:787-793, . (PMID: 23434100)

Ha, Y. S. Salmasi, A. Karellas, M. Singer, E. A. Kim, J. H. Han, M. Partin, A. W. Kim, W. J. Lee, D. H. Kim, I. Y. Increased Incidence of Pathologically Nonorgan Confined Prostate Cancer in African-American Men Eligible for Active Surveillance. Urology, 81:831-835, . (PMID: 23465143)

Jung, S. J. Oh, S. Lee, G. T. Chung, J. Min, K. Yoon, J. Kim, W. Ryu, D. S. Kim, I. Y. Kang, D. I. Clinical Significance of Wnt/beta-Catenin Signalling and Androgen Receptor Expression in Prostate Cancer. World J Mens Health, 31:36-46, . (PMID: 23658864, PMCID: PMC3640151)

Kim, I. Y. Reply. Urology, In process, . (PMID: 23465146)

Ha, Y. S. Goodin, S. Dipaola, R. S. Kim, I. Y. Enzalutamide for the treatment of castration-resistant prostate cancer. Drugs Today (Barc), 49:7-13, . (PMID: 23362491)

Park, H. J. Ha, Y. S. Park, S. Y. Kim, Y. T. Lee, T. Y. Kim, J. H. Lee, D. H. Kim, W. J. Kim, I. Y. Incidence of Upgrading and Upstaging in Patients with Low-Volume Gleason Score 3+4 Prostate Cancers at Biopsy: Finding a New Group Eligible for Active Surveillance. Urol Int, 90:301-305, . (PMID: 23391718)

Ha, Y. S. Chihara, Y. Yoon, H. Y. Kim, Y. J. Kim, T. H. Woo, S. H. Yun, S. J. Kim, I. Y. Hirao, Y. Kim, W. J. Downregulation of fumarate hydratase is related to tumorigenesis in sporadic renal cell cancer. Urol Int, 90:233-239, . (PMID: 23295344)

Kang, D. I. Chung, J. I. Ha, H. K. Min, K. Yoon, J. Kim, W. Seo, W. I. Kang, P. m. Jung, S. J. Kim, I. Y. Korean prostate cancer patients have worse disease characteristics than their American counterparts. Asian Pac J Cancer Prev, 14:6913-6917, . (PMID: 24377625)

Yun, S. J. Yoon, H. Y. Bae, S. C. Lee, O. J. Choi, Y. H. Moon, S. K. Kim, I. Y. Kim, W. J. Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancer. Prostate Cancer Prostatic Dis, 15:369-373, . (PMID: 22890388)

Jeong, P. Min, B. D. Ha, Y. S. Song, P. H. Kim, I. Y. Ryu, K. H. Kim, J. H. Yun, S. J. Kim, W. J. RUNX3 methylation in normal surrounding urothelium of patients with non-muscle-invasive bladder cancer: potential role in the prediction of tumor progression. Eur J Surg Oncol, 38:1095-1100, . (PMID: 22884471)

Yun, S. J. Jeong, P. Kim, W. T. Kim, T. H. Lee, Y. S. Song, P. H. Choi, Y. H. Kim, I. Y. Moon, S. K. Kim, W. J. Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer. Int J Oncol, 41:1871-1878, . (PMID: 22961325)

Kim, J. J. Ha, Y. S. Kim, J. H. Jeon, S. S. Lee, D. H. Kim, W. J. Kim, I. Y. Independent predictors of recovery of continence 3 months after robot-assisted laparoscopic radical prostatectomy. J Endourol, 26:1290-1295, . (PMID: 22651546, PMCID: PMC3466068)

Lee, J. H. Lee, G. T. Kwon, S. J. Jeong, J. Ha, Y. S. Kim, W. J. Kim, I. Y. CREBZF, a novel Smad8-binding protein. Mol Cell Biochem, 368:147-153, . (PMID: 22707059)

Kim, E. J. Yan, C. Ha, Y. S. Jeong, P. Yi Kim, I. Moon, S. K. Choi, Y. H. Kim, W. J. Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: a novel approach using peptide nucleic acid-mediated, real-time PCR clamping. Urol Oncol, 30:673-679, . (PMID: 20884250)

Ha, Y. S. Kim, J. S. Yoon, H. Y. Jeong, P. Kim, T. H. Yun, S. J. Lee, S. C. Kim, G. Y. Choi, Y. H. Moon, S. K. Yi Kim, I. Kim, W. J. Novel combination markers for predicting progression of nonmuscle invasive bladder cancer. Int J Cancer, 131:E501-E507, . (PMID: 22025348)

Kang, D. I. Woo, S. H. Lee, D. H. Kim, I. Y. Incidence of Port-Site Hernias After Robot-Assisted Radical Prostatectomy with the Fascial Closure of Only the Midline 12-mm Port Site. J Endourol, 26:848-851, . (PMID: 22283233)

Ha, Y. S. Jeong, P. Kim, J. S. Kwon, W. A. Kim, I. Y. Yun, S. J. Kim, G. Y. Choi, Y. H. Moon, S. K. Kim, W. J. Tumorigenic and prognostic significance of RASSF1A expression in low-grade (WHO grade 1 and grade 2) nonmuscle-invasive bladder cancer. Urology, 79:1411.e1-1411.e6, . (PMID: 22446336)

Kim, J. S. Chae, Y. Ha, Y. S. Kim, I. Y. Byun, S. S. Yun, S. J. Kim, W. J. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer. Clin Genitourin Cancer, 10:114-120, . (PMID: 22382007)

Yan, C. Kim, Y. W. Ha, Y. S. Kim, I. Y. Kim, Y. J. Yun, S. J. Moon, S. K. Bae, S. C. Kim, W. J. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer. J Surg Oncol, 105:425-430, . (PMID: 22311819)

Yun, S. J. Ha, Y. S. Chae, Y. Kim, J. S. Kim, I. Y. Kim, W. J. The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population. Ann Oncol, 23:401-405, . (PMID: 21515665)

Chou, Y. W. Chaturvedi, N. K. Ouyang, S. Lin, F. F. Kaushik, D. Wang, J. Kim, I. Lin, M. F. Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells. Cancer Lett, 311:177-186, . (PMID: 21862211, PMCID: PMC3232184)

Kang, D. I. Jang, T. L. Jeong, J. Choi, E. Y. Johnson, K. Lee, D. H. Kim, W. J. Kim, I. Y. Pathological findings following radical prostatectomy in patients who are candidates for active surveillance: impact of varying PSA levels. Asian J Androl, 13:838-841, . (PMID: 21785442)

Kim, W. T. Yun, S. J. Choi, Y. D. Kim, G. Y. Moon, S. K. Choi, Y. H. Kim, I. Y. Kim, W. J. Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels. J Korean Med Sci, 26:1214-1218, . (PMID: 21949470, PMCID: PMC3173509)

Kim, W. T. Choi, Y. D. Park, C. Kim, Y. W. Yun, S. J. Kim, I. Y. Kim, W. J. Parathyroid hormone is not involved in prostate growth in patients with benign prostatic hyperplasia. Prostate, 71:1210-1215, . (PMID: 21656831)

Lee, G. T. Jung, Y. S. Lee, J. H. Kim, W. J. Kim, I. Y. Bone morphogenetic protein 6-induced interleukin-1beta expression in macrophages requires PU.1/Smad1 interaction. Mol Immunol, 48:1540-1547, . (PMID: 21571370)

Kim, Y. J. Yoon, H. Y. Kim, S. K. Kim, Y. W. Kim, E. J. Kim, I. Y. Kim, W. J. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling. Clin Cancer Res, 17:4523-4530, . (PMID: 21571867)

Jeong, P. Ha, Y. S. Cho, I. C. Yun, S. J. Yoo, E. S. Kim, I. Y. Choi, Y. H. Moon, S. K. Kim, W. J. Three-gene signature predicts disease progression of non-muscle invasive bladder cancer. Oncol Lett, 2:679-684, . (PMID: 22848249, PMCID: PMC3406413)

Woo, S. H. Kim, I. Y. Editorial comment for Rebuck et al. J Endourol, 25:960-961, . (PMID: 21574865)

Kim, W. J. Kim, S. K. Jeong, P. Yun, S. J. Cho, I. C. Kim, I. Y. Moon, S. K. Um, H. D. Choi, Y. H. A four-gene signature predicts disease progression in muscle invasive bladder cancer. Mol Med, 17:478-485, . (PMID: 21308147, PMCID: PMC3105150)

Jeong, J. Choi, E. Y. Kang, D. I. Ercolani, M. Lee, D. H. Kim, W. J. Kim, I. Y. Pathologic implications of prostatic anterior fat pad. Urol Oncol, In process, . (PMID: 21396837)

Lee, G. T. Kwon, S. J. Lee, J. H. Jeon, S. S. Jang, K. T. Choi, H. Y. Lee, H. M. Kim, W. J. Lee, D. H. Kim, I. Y. Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop. Prostate, In process, . (PMID: 21374653)

Choi, E. Y. Jeong, J. Kang, D. I. Johnson, K. Ercolani, M. Jang, T. Lee, D. H. Kim, W. J. Kim, I. Y. Impact of robot-assisted radical prostatectomy on health-related quality of life in patients with lower urinary tract symptoms. Int J Urol, In process, . (PMID: 21342297)

Ha, Y. S. Yan, C. Jeong, P. Kim, W. T. Yun, S. J. Kim, I. Y. Moon, S. K. Kim, W. J. GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer. J Korean Med Sci, 26:231-236, . (PMID: 21286014, PMCID: PMC3031007)